Log in
NASDAQ:ONVO

Organovo Stock Forecast, Price & News

$7.20
+0.09 (+1.27 %)
(As of 09/18/2020 12:00 AM ET)
Add
Compare
Today's Range
$7.13
Now: $7.20
$7.47
50-Day Range
$0.56
MA: $10.00
$15.34
52-Week Range
$3.87
Now: $7.20
$18.60
Volume36,971 shs
Average Volume62,953 shs
Market Capitalization$47.02 million
P/E RatioN/A
Dividend YieldN/A
Beta0.91
Organovo Holdings, Inc., a biotechnology company, provides therapeutic and drug profiling capabilities based on its 3D bioprint tissues that emulate human biology and diseases. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised mammalian cells; and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture. The company offers ExVive human liver tissue and ExVive human kidney tissue used for predictive preclinical testing of drug compounds. It is also developing in vivo liver tissues to treat a range of rare, life-threatening diseases. In addition, the company offers preclinical in vitro disease modeling platforms, including a range of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis conditions. Further, it involved in various programs to develop its NovoTissues transplantable tissues to address various serious unmet medical needs in adult and pediatric populations primarily focusing on liver disease. The company was founded in 2007 and is headquartered in San Diego, California.
Read More
Organovo logo

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.50 out of 5 stars


Industry, Sector and Symbol

Industry Biological products, except diagnostic
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:ONVO
CUSIPN/A
Phone858-224-1000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$2.20 million
Book Value$4.08 per share

Profitability

Net Income$-18,710,000.00
Net Margins-798.68%

Miscellaneous

Employees70
Market Cap$47.02 million
Next Earnings Date11/5/2020 (Estimated)
OptionableOptionable
$7.20
+0.09 (+1.27 %)
(As of 09/18/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive ONVO News and Ratings via Email

Sign-up to receive the latest news and ratings for ONVO and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Organovo (NASDAQ:ONVO) Frequently Asked Questions

How has Organovo's stock been impacted by COVID-19 (Coronavirus)?

Organovo's stock was trading at $5.20 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, ONVO stock has increased by 38.5% and is now trading at $7.20.
View which stocks have been most impacted by COVID-19
.

When is Organovo's next earnings date?

Organovo is scheduled to release its next quarterly earnings announcement on Thursday, November 5th 2020.
View our earnings forecast for Organovo
.

How were Organovo's earnings last quarter?

Organovo Holdings Inc (NASDAQ:ONVO) issued its quarterly earnings results on Monday, August, 10th. The medical research company reported ($0.40) EPS for the quarter. Organovo had a negative return on equity of 54.41% and a negative net margin of 798.68%.
View Organovo's earnings history
.

When did Organovo's stock split? How did Organovo's stock split work?

Organovo shares reverse split on the morning of Wednesday, August 19th 2020. The 1-20 reverse split was announced on Monday, August 17th 2020. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, August 18th 2020. An investor that had 100 shares of Organovo stock prior to the reverse split would have 5 shares after the split.

Are investors shorting Organovo?

Organovo saw a decrease in short interest in August. As of August 31st, there was short interest totaling 124,100 shares, a decrease of 90.9% from the August 15th total of 1,370,000 shares. Based on an average daily trading volume, of 77,900 shares, the days-to-cover ratio is currently 1.6 days. Approximately 1.9% of the company's stock are short sold.
View Organovo's Short Interest
.

Who are some of Organovo's key competitors?

What other stocks do shareholders of Organovo own?

Who are Organovo's key executives?

Organovo's management team includes the following people:
  • Mr. Taylor J. Crouch, CEO, Pres & Director (Age 59)
  • Mr. Craig Kussman, Chief Financial Officer (Age 60)
  • Ms. Jennifer Kinsbruner Bush, Sr. VP, Compliance Officer, Gen. Counsel & Corp. Sec. (Age 44)
  • Mr. Paul Gallant, Gen. Mang. (Age 54)
  • Mr. Steve E. Kunszabo, VP of Investor Relations & Corp. Communications

What is Organovo's stock symbol?

Organovo trades on the NASDAQ under the ticker symbol "ONVO."

Who are Organovo's major shareholders?

Organovo's stock is owned by a variety of retail and institutional investors. Top institutional investors include Sumitomo Mitsui Trust Holdings Inc. (7.50%), WINTON GROUP Ltd (0.18%), Jane Street Group LLC (0.10%), Avantax Advisory Services Inc. (0.08%), UBS Group AG (0.07%) and Commonwealth Equity Services LLC (0.07%).
View institutional ownership trends for Organovo
.

Which major investors are selling Organovo stock?

ONVO stock was sold by a variety of institutional investors in the last quarter, including Sumitomo Mitsui Trust Holdings Inc., WINTON GROUP Ltd, and Commonwealth Equity Services LLC.
View insider buying and selling activity for Organovo
.

Which major investors are buying Organovo stock?

ONVO stock was acquired by a variety of institutional investors in the last quarter, including Jane Street Group LLC, Avantax Advisory Services Inc., and UBS Group AG.
View insider buying and selling activity for Organovo
.

How do I buy shares of Organovo?

Shares of ONVO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Organovo's stock price today?

One share of ONVO stock can currently be purchased for approximately $7.20.

How big of a company is Organovo?

Organovo has a market capitalization of $47.02 million and generates $2.20 million in revenue each year. Organovo employs 70 workers across the globe.

What is Organovo's official website?

The official website for Organovo is www.organovo.com.

How can I contact Organovo?

Organovo's mailing address is 440 STEVENS AVENUE SUITE 200, SOLANA BEACH CA, 92075. The medical research company can be reached via phone at 858-224-1000 or via email at [email protected]

This page was last updated on 9/20/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.